Kristin Ermanbriks
Corporate Officer/Principal at Nexttobe AB
Profile
Ms. Kristin Ermanbriks is a Manager-Corporate Administration at Q-Med AB and Project Coordinator at Nexttobe AB.
Ms. Ermanbriks was previously employed as Executive Assistant by Conpharm AB, Executive Assistant by University of Uppsala, and Marketing Assistant by Pharmacia International BV.
Kristin Ermanbriks active positions
| Companies | Position | Start |
|---|---|---|
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Corporate Officer/Principal | - |
Former positions of Kristin Ermanbriks
| Companies | Position | End |
|---|---|---|
| Pharmacia International BV | Sales & Marketing | - |
| SLOTTSVIKEN FASTIGHETSAKTIEBOLAG | Corporate Officer/Principal | - |
| University of Uppsala | Corporate Officer/Principal | - |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Chief Administrative Officer | 2011-07-27 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SLOTTSVIKEN FASTIGHETSAKTIEBOLAG | Finance |
| Private companies | 3 |
|---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
| Pharmacia International BV |
- Stock Market
- Insiders
- Kristin Ermanbriks
